A Comparative Study of Bayesian Optimal Interval (BOIN) Design With Interval 3 + 3 (i3 + 3) Design for Phase I Oncology Dose-Finding Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Comparative Study of Bayesian Optimal Interval (BOIN) Design With Interval 3 + 3 (i3 + 3) Design for Phase I Oncology Dose-Finding Trials

Published:2020-09-14 Issue:2 Volume:13 Page:147-155
ISSN:1946-6315
Container-title:Statistics in Biopharmaceutical Research
language:en
Short-container-title:Statistics in Biopharmaceutical Research

Author:

Zhou Yanhong¹,Li Ruobing²,Yan Fangrong³^ORCID,Lee J. Jack¹,Yuan Ying¹

Affiliation:

1. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX

2. Office of Biostatistics and Clinical Pharmacology, Center for Drug Evaluation, National Medical Products Administration, Beijing, China

3. School of Science, China Pharmaceutical University, Nanjing, China

Funder

National Cancer Institute

Cancer Prevention and Research Institute of Texas

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/19466315.2020.1811147

Reference36 articles.

1. Cancer phase I clinical trials: efficient dose escalation with overdose control

2. The bivariate continual reassessment method

3. Dose Finding by the Continual Reassessment Method

4. Sequential Designs for Phase I Clinical Trials with Late-Onset Toxicities

5. Bayesian adaptive clinical trials: a dream for statisticians only?

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I CAR-T Clinical Trials Review;Anticancer Research;2022-12

2. AIDE : Adaptive intrapatient dose escalation designs to accelerate Phase I clinical trials;Pharmaceutical Statistics;2022-11-05

3. Rightsizing the Dosing of Modern Oncology Drugs: Mind the Gap;Indian Journal of Medical and Paediatric Oncology;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3